Rivaroxaban
CURRENT LOCATION:
HOMEKey projects》Rivaroxaban

Rivaroxaban

Project NameRivaroxaban 

Registration Classification:3+6

Formulations and specifications Tablets: 10mg 

IndicationsFor the prevention of  deep vein thrombosis (DVT) and pulmonary embolism (PE) formation after hip and knee replacement surgery.

Original Research CompanyBayer

Progress Recently reported to the State Bureau 

Category :Antithrombotic drugs 

Links:

地址:北京市丰台区造甲街南里5号4A楼2层
电话:010-63716441 63717341 传真:010-63728443
COPYRIGHT (C) 2014 Beijing Mega Pharmaceutical Science and Technology Co.,ltd. ALL RIGHTS RESERVED
版权所有 北京满格医药科技有限公司 京ICP备12000952号